Precision Biosciences (DTIL) Shares Outstanding (2018 - 2026)
Precision Biosciences (DTIL) posted quarterly Shares Outstanding (Entity) of $25.8 million for Q1 2026, up 144.26% year-over-year from $10.6 million in Q1 2025, and up 101.41% quarter-over-quarter from $12.8 million in Q4 2025.
Precision Biosciences (DTIL) Shares Outstanding (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has reported Shares Outstanding (Entity) for 9 consecutive years, with $25.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 144.26% year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at $25.8 million (up 144.26% YoY), while the FY2025 annual figure was $12.8 million, up 87.71% from the prior year.
- Shares Outstanding (Entity) improved to $25.8 million in Q1 2026 per DTIL's latest filing, from $12.8 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $25.8 million in Q1 2026 and bottomed at $2.1 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $7.4 million across 5 years, with a median of $5.1 million in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) grew 4.25% — and 2026, when it jumped 144.26%.
- Precision Biosciences' Shares Outstanding (Entity) stood at $2.9 million in 2022, then soared by 43.06% to $4.2 million in 2023, then surged by 63.04% to $6.8 million in 2024, then jumped by 87.71% to $12.8 million in 2025, then soared by 101.41% to $25.8 million in 2026.
- Business Quant data shows DTIL's Shares Outstanding (Entity) at $25.8 million in Q1 2026, $12.8 million in Q4 2025, and $12.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Precision Biosciences | 228.31 Mn | 140.77 Mn | - | 25.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.86 Mn |
| Mar 31, 2026 | 24.63 Mn |
| Dec 31, 2025 | 12.83 Mn |
| Sep 30, 2025 | 11.82 Mn |
| Jun 30, 2025 | 11.05 Mn |
| Mar 31, 2025 | 9.29 Mn |
| Dec 31, 2024 | 6.83 Mn |
| Sep 30, 2024 | 7.29 Mn |
| Jun 30, 2024 | 6.97 Mn |
| Mar 31, 2024 | 5.06 Mn |
| Dec 31, 2023 | 3.84 Mn |
| Sep 30, 2023 | 3.84 Mn |
| Jun 30, 2023 | 3.80 Mn |
| Mar 31, 2023 | 3.71 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Sep 30, 2022 | 3.69 Mn |
| Jun 30, 2022 | 2.26 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 1.96 Mn |
| Sep 30, 2021 | 1.99 Mn |